🇺🇸 FDA

Drug profile · INN

gallium ga-68 edotreotide

GALLIUM GA 68 EDOTREOTIDE

approved
US status
approved
Patents linked
0
News articles
0

Quick answer

gallium ga-68 edotreotide (GALLIUM GA 68 EDOTREOTIDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.

Key facts

INN gallium ga-68 edotreotide
Brand GALLIUM GA 68 EDOTREOTIDE
Route INTRAVENOUS
Formulation SOLUTION

Frequently asked questions

What is gallium ga-68 edotreotide?

gallium ga-68 edotreotide (GALLIUM GA 68 EDOTREOTIDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.

What is the brand name for gallium ga-68 edotreotide?

GALLIUM GA 68 EDOTREOTIDE is a marketed brand name for gallium ga-68 edotreotide. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of gallium ga-68 edotreotide?

gallium ga-68 edotreotide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.